Au­toim­mune CAR-Ts are un­der the mi­cro­scope af­ter Ca­balet­ta’s safe­ty is­sue in lu­pus

Eyes are on CAR-T ther­a­py clin­i­cal tri­als in au­toim­mune dis­eases for po­ten­tial­ly more se­ri­ous side ef­fects, af­ter Ca­balet­ta Bio’s can­di­date was linked with a high …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER